Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Is it safe or cost-effective to import medicine from Canada's or other countries' drug supplies?

 

Pharmacy to pharmacy marketplaces for medicine have been used to traffick counterfeits. PSM is urging better safety measures

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations

May 5, 2025
graph comparing negative health effects between compounded and manufactured glp-1s

New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events. GIlead Sciences is suing another New York City pharmacy that allegedly sold counterfeit HIV medicine.

ALERT: New FDA Warning Letter to www.thesafepills.org

April 29, 2025

The FDA has issued a warning to the operators of the online pharmacy www.thesafepills.org for illegally selling unapproved and misbranded opioid medications, including tapentadol products marketed as Aspadol and Typendol. These unauthorized drugs, sold without a prescription, pose significant health risks such as overdose, addiction, and even death.

April 28, 2025: SafeChain Solutions executive admits to criminal wire fraud in HIV drug diversion case

April 29, 2025
jumbled box of bottles of medicine

One of SafeChain’s three owners pleaded guilty. The company collected secondhand HIV medicines from patients and resold them to licensed U.S. pharmacies, forging paperwork to make them look legitimate.

April 21, 2025: Kentucky doctor pleads guilty after injecting patients with semaglutide from unregistered sources

April 22, 2025
screenshot from a website selling vials of "research" semaglutide

A Kentucky doctor treated weight loss patients with research chemicals; CBP seized 90,000 alprazolam pills being smuggled into the U.S.

FDA Alert: Counterfeit Ozempic found in U.S. Supply Chain

April 15, 2025

The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the U.S. drug supply chain. The falsified products, labeled with lot number PAR0362 and serial numbers beginning with 51746517, were seized by the FDA on April 9, 2025. Their contents and safety are unverified and pose serious health risks.

New initiative: Best practices for online pharmacy-to-pharmacy marketplaces

April 15, 2025

PSM is seeking input on developing a set of best practices to reduce sales of counterfeit and diverted medicines on online pharmacy-to-pharmacy marketplaces.

April 14, 2025: Regulators announce a third instance of counterfeit Ozempic injections in the U.S. drug supply

April 14, 2025
Boxes showing the lot and serial number of counterfeit Ozempic

The FDA announced that it had seized counterfeit Ozempic injections on April 9. PSM testified at a congressional hearing.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Who's investigating a company selling research-grade weight loss injections?  Find out..

Updates on two federal prosecutions.

youtube-video-thumbnail

Click the images below to see more recent videos.